Penumbra, Inc. Schedules Third Quarter 2022 Earnings Release and Conference Call for November 3, 2022
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Penumbra, Inc. (NYSE: PEN) has scheduled a conference call on November 3, 2022, at 4:30 PM ET to discuss its third quarter 2022 financial results. The earnings release will be made available after market close on the same day. Interested parties can access the call by dialing (888) 330-2443 or via the webcast on the company's website. Penumbra focuses on innovative therapies and has a significant presence in over 100 countries, supporting healthcare providers with its broad product portfolio.
Positive
- Scheduled earnings call indicates proactive communication with investors.
- Broad international presence in over 100 countries supports market growth.
Negative
- None.
Details
News Market Reaction – PEN
The recorded move for PEN in the trading session of this news was -6.88%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALAMEDA, Calif., Oct. 6, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2022 after market close on Thursday, November 3, 2022 at 4:30 PM Eastern Time. A press release with third quarter 2022 financial results will be issued after market close that day.
Webcast & Conference Call Information
The conference call can be accessed live over the phone by dialing (888) 330-2443 for domestic and international callers (conference id: 4604622), or the webcast can be accessed on the "Events" section under the "Investors" tab of the Company's website at: www.penumbrainc.com. The webcast will be available on the Company's website for at least two weeks following the completion of the call.
About Penumbra
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses challenging medical conditions in markets with significant unmet need. Penumbra supports healthcare providers, hospitals and clinics in more than 100 countries. For more information, visit www.penumbrainc.com and connect on Twitter and LinkedIn.
Investor Relations
Penumbra, Inc.
510-995-2461
Investors@penumbrainc.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-schedules-third-quarter-2022-earnings-release-and-conference-call-for-november-3-2022-301643172.html
SOURCE Penumbra, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.